| Coronavirus disease 2019–associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management L Ortega‐Paz, D Capodanno, G Montalescot, DJ Angiolillo Journal of the American Heart Association 10 (3), e019650, 2021 | 175 | 2021 |
| Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events … L Ortega-Paz, D Capodanno, T Gori, H Nef, A Latib, G Caramanno, CM Di, ... EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2017 | 132 | 2017 |
| Pre-eclampsia/eclampsia and hepatic rupture P Vigil-De Gracia, L Ortega-Paz International Journal of Gynecology & Obstetrics 118 (3), 186-189, 2012 | 100 | 2012 |
| Magnesium-based resorbable scaffold versus permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: the MAGSTEMI randomized … M Sabate, F Alfonso, A Cequier, S Romani, P Bordes, A Serra, A Iniguez, ... Circulation 140 (23), 1904-1916, 2019 | 84 | 2019 |
| Retinal detachment in association with pre-eclampsia, eclampsia, and HELLP syndrome P Vigil-De Gracia, L Ortega-Paz International Journal of Gynecology & Obstetrics 114 (3), 223-225, 2011 | 75 | 2011 |
| Disparate miRNA expression in serum and plasma of patients with acute myocardial infarction: a systematic and paired comparative analysis A Mompeón, L Ortega-Paz, X Vidal-Gómez, TJ Costa, D Pérez-Cremades, ... Scientific reports 10 (1), 5373, 2020 | 74 | 2020 |
| Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis … L Ortega-Paz, M Galli, D Capodanno, F Franchi, F Rollini, B Bikdeli, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (7), 677-686, 2022 | 61 | 2022 |
| Effects of ticagrelor, prasugrel, or clopidogrel on endothelial function and other vascular biomarkers: a randomized crossover study S Ariotti, L Ortega-Paz, M van Leeuwen, S Brugaletta, S Leonardi, ... JACC: Cardiovascular Interventions 11 (16), 1576-1586, 2018 | 57 | 2018 |
| Conocimientos y actitudes acerca de la investigación científica en los estudiantes de medicina de la Universidad de Panamá SAS Villarreal, JZ Cisneros, CO Loubon, A Yau, F Castro, JMB Castro, ... Archivos de medicina 9 (3), 1, 2013 | 52 | 2013 |
| Adenosine and ticagrelor plasma levels in patients with and without ticagrelor-related dyspnea L Ortega-Paz, S Brugaletta, S Ariotti, KM Akkerhuis, A Karagiannis, ... Circulation 138 (6), 646-648, 2018 | 40 | 2018 |
| 10-Year follow-up of patients with everolimus-eluting versus bare-metal stents after ST-segment elevation myocardial infarction S Brugaletta, J Gomez-Lara, L Ortega-Paz, V Jimenez-Diaz, M Jimenez, ... Journal of the American College of Cardiology 77 (9), 1165-1178, 2021 | 37 | 2021 |
| Acute and chronic effects of COVID-19 on the cardiovascular system V Arévalos, L Ortega-Paz, JJ Rodríguez-Arias, M Calvo Lopez, ... Journal of Cardiovascular Development and Disease 8 (10), 128, 2021 | 31 | 2021 |
| Capacitación en investigación brindada a los estudiantes de medicina de la facultad de medicina de la Universidad de Panamá. C Ortega-Loubon, J Zúñiga-Cisneros, F Castro, JM Barría-Castro, ... Archivos de medicina 9 (3), 2013 | 31 | 2013 |
| Amphilimus-vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial R Romaguera, P Salinas, J Gomez-Lara, S Brugaletta, ... European Heart Journal 43 (13), 1320-1330, 2022 | 30 | 2022 |
| Long-term coronary functional assessment of the infarct-related artery treated with everolimus-eluting bioresorbable scaffolds or everolimus-eluting metallic stents: insights … J Gomez-Lara, S Brugaletta, L Ortega-Paz, B Vandeloo, E Moscarella, ... JACC: Cardiovascular Interventions 11 (16), 1559-1571, 2018 | 27 | 2018 |
| Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention M Galli, L Ortega-Paz, F Franchi, F Rollini, DJ Angiolillo Pharmacogenomics 23 (13), 723-737, 2022 | 26 | 2022 |
| Impact of body mass index on 5-year clinical outcomes in patients with ST–segment elevation myocardial infarction after everolimus-eluting or bare-metal stent implantation E Moscarella, G Spitaleri, S Brugaletta, SS Farrarons, A Pernigotti, ... The American journal of cardiology 120 (9), 1460-1466, 2017 | 25 | 2017 |
| Five-Year Optical Coherence Tomography in Patients With ST-Segment–Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents J Gomez-Lara, S Brugaletta, F Jacobi, L Ortega-Paz, M Ñato, G Roura, ... Circulation: Cardiovascular Interventions 9 (10), e003670, 2016 | 24 | 2016 |
| Bioresorbable scaffolds versus permanent sirolimus-eluting stents in J Gomez-Lara, L Ortega-Paz, S Brugaletta, J Cuesta, S Romaní, A Serra, ... Lancet 369 (9576), 1869-1875, 2007 | 22 | 2007 |
| Factor XI inhibitors in early clinical trials: a meta-analysis M Galli, R Laborante, L Ortega-Paz, F Franchi, F Rollini, D D'Amario, ... Thrombosis and Haemostasis 123 (06), 576-584, 2023 | 21 | 2023 |
Salvatore BrugalettaHospital ClinicVerified email at clinic.cat
